Volume 77, no. 2, pages 622–631, 2009. Page 630, Acknowledgments, lines 1 and 2 should read: This work was funded by the European FP6 integrated project TBVAC to Stefan H. E. Kaufmann and to Adrian V. S. Hill and was supported by funding from the NIHR Oxford Biomedical Research Centre program.
. 2011 May;79(5):2133. doi: 10.1128/IAI.00188-11
Immunogenicity and Protective Efficacy of Prime-Boost Regimens with Recombinant ΔureC hly+ Mycobacterium bovis BCG and Modified Vaccinia Virus Ankara Expressing M. tuberculosis Antigen 85A against Murine Tuberculosis
Elma Z Tchilian
1, Christiane Desel
1, Emily K Forbes
1, Silke Bandermann
1, Clare R Sander
1, Adrian V S Hill
1, Helen McShane
1, Stefan H E Kaufmann
1
Elma Z Tchilian
1The Jenner Institute, Oxford University, ORCRB, Roosevelt Drive, Headington, Oxford OX3 7DQ, United Kingdom, and Max Planck Institute for Infection Biology, Charitéplatz 1, 10117 Berlin, Germany
Find articles by Elma Z Tchilian
Christiane Desel
1The Jenner Institute, Oxford University, ORCRB, Roosevelt Drive, Headington, Oxford OX3 7DQ, United Kingdom, and Max Planck Institute for Infection Biology, Charitéplatz 1, 10117 Berlin, Germany
Find articles by Christiane Desel
Emily K Forbes
1The Jenner Institute, Oxford University, ORCRB, Roosevelt Drive, Headington, Oxford OX3 7DQ, United Kingdom, and Max Planck Institute for Infection Biology, Charitéplatz 1, 10117 Berlin, Germany
Find articles by Emily K Forbes
Silke Bandermann
1The Jenner Institute, Oxford University, ORCRB, Roosevelt Drive, Headington, Oxford OX3 7DQ, United Kingdom, and Max Planck Institute for Infection Biology, Charitéplatz 1, 10117 Berlin, Germany
Find articles by Silke Bandermann
Clare R Sander
1The Jenner Institute, Oxford University, ORCRB, Roosevelt Drive, Headington, Oxford OX3 7DQ, United Kingdom, and Max Planck Institute for Infection Biology, Charitéplatz 1, 10117 Berlin, Germany
Find articles by Clare R Sander
Adrian V S Hill
1The Jenner Institute, Oxford University, ORCRB, Roosevelt Drive, Headington, Oxford OX3 7DQ, United Kingdom, and Max Planck Institute for Infection Biology, Charitéplatz 1, 10117 Berlin, Germany
Find articles by Adrian V S Hill
Helen McShane
1The Jenner Institute, Oxford University, ORCRB, Roosevelt Drive, Headington, Oxford OX3 7DQ, United Kingdom, and Max Planck Institute for Infection Biology, Charitéplatz 1, 10117 Berlin, Germany
Find articles by Helen McShane
Stefan H E Kaufmann
1The Jenner Institute, Oxford University, ORCRB, Roosevelt Drive, Headington, Oxford OX3 7DQ, United Kingdom, and Max Planck Institute for Infection Biology, Charitéplatz 1, 10117 Berlin, Germany
Find articles by Stefan H E Kaufmann
1The Jenner Institute, Oxford University, ORCRB, Roosevelt Drive, Headington, Oxford OX3 7DQ, United Kingdom, and Max Planck Institute for Infection Biology, Charitéplatz 1, 10117 Berlin, Germany
Copyright © 2011, American Society for Microbiology
PMCID: PMC3088157
This corrects the article "Immunogenicity and Protective Efficacy of Prime-Boost Regimens with Recombinant ΔureC hly+ Mycobacterium bovis BCG and Modified Vaccinia Virus Ankara Expressing M. tuberculosis Antigen 85A against Murine Tuberculosis " in volume 77 on page 622.